Drug Costs Developments after Patent Expiry of Enalapril, Fluoxetine and Ranitidine - Concepedia

Concepedia

Publication | Closed Access

Drug Costs Developments after Patent Expiry of Enalapril, Fluoxetine and Ranitidine

20

Citations

10

References

2005

Year

Cornelis Boersma, Rogier Klok, Jasper M Bos, Mark Naunton, Paul B. van den Berg, Lolkje T. W. de Jong-van den Berg, Maarten J. Postma

Applied Health Economics and Health Policy

Drug Costs DevelopmentsHealth EconomicsPharmacologyPatent ExpiryPharmacoeconomicsTherapeutic PatentPharmacotherapyPatentabilityDrug DevelopmentMedicineIntellectual PropertyDrug DiscoveryPharmaceutical Research

References

	Year	Citations

Page 1

Page 1